000			02025 a2200565 4500
005			20250518070410.0
264		0	_c20200706
008			202007s 0 0 eng d
022			_a1941-7705
024	7		_a10.1161/CIRCOUTCOMES.119.006073 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchwartz, Lisa M
245	0	0	_aRandomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion. _h[electronic resource]
260			_bCirculation. Cardiovascular quality and outcomes _c11 2019
300			_ae006073 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAdvertising
650	0	4	_aAttitude of Health Personnel
650	0	4	_aCardiovascular Diseases _xdiagnosis
650	0	4	_aClinical Decision-Making
650	0	4	_aDrug Labeling
650	0	4	_aEducation, Medical, Continuing
650	0	4	_aFatty Acids, Omega-3 _xadverse effects
650	0	4	_aFemale
650	0	4	_aHealth Knowledge, Attitudes, Practice
650	0	4	_aHumans
650	0	4	_aHypertriglyceridemia _xblood
650	0	4	_aHypolipidemic Agents _xadverse effects
650	0	4	_aMale
650	0	4	_aMarketing of Health Services
650	0	4	_aMiddle Aged
650	0	4	_aOff-Label Use
650	0	4	_aPatient Safety
650	0	4	_aPatient Selection
650	0	4	_aPhysicians _xpsychology
650	0	4	_aPractice Patterns, Physicians'
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
700	1		_aWoloshin, Steven
700	1		_aLu, Zhigang
700	1		_aRoss, Kathryn M
700	1		_aTessema, Frazer A
700	1		_aPeter, Doris
700	1		_aKesselheim, Aaron S
773	0		_tCirculation. Cardiovascular quality and outcomes _gvol. 12 _gno. 11 _gp. e006073
856	4	0	_uhttps://doi.org/10.1161/CIRCOUTCOMES.119.006073 _zAvailable from publisher's website
999			_c30294044 _d30294044